Bg pattern

EXEMESTANE AUROVITAS 25 mg FILM-COATED TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use EXEMESTANE AUROVITAS 25 mg FILM-COATED TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Exemestane Aurovitas 25 mg Film-Coated Tablets EFG

Read all of this leaflet carefully before you start taking this medicine, because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you, do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
  • If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

In this leaflet:

  1. What is Exemestane Aurovitas and what is it used for
  2. What you need to know before you take Exemestane Aurovitas
  3. How to take Exemestane Aurovitas
  4. Possible side effects
  5. Storage of Exemestane Aurovitas
  6. Contents of the pack and other information

1. What is Exemestane Aurovitas and what is it used for

This medicine is called Exemestane Aurovitas. Exemestane belongs to a group of medicines called aromatase inhibitors. These medicines interfere with a substance called aromatase, which is needed to produce female sex hormones, estrogens, especially in postmenopausal women. The reduction of estrogen levels in the body is a way to treat hormone-dependent breast cancer.

This medicine is used to treat hormone-dependent breast cancer in early stages in postmenopausal women after completing 2-3 years of treatment with tamoxifen.

It is also used to treat advanced hormone-dependent breast cancer in postmenopausal women when other hormonal treatment has not been effective enough.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you take Exemestane Aurovitas

Do not take Exemestane Aurovitas

  • if you are or have been previously allergic to exemestane, soy, peanut, lecithin, or any of the other components of this medicine (listed in section 6),
  • if you have not yet reached menopause, i.e., if you still have your period,
  • if you are pregnant, think you may be pregnant, or are breastfeeding.

Warnings and precautions

Talk to your doctor or pharmacist before starting to take this medicine:

  • Before starting treatment with this medicine, your doctor may perform a blood test to make sure you have reached menopause.
  • Periodically, your vitamin D levels will also be checked before starting treatment, as they may be too low in the early stages of breast cancer. You will be given a vitamin D supplement if your levels are below normal.
  • Before taking this medicine, tell your doctor if you have any liver or kidney problems.
  • Tell your doctor if you have a history of or suffer from any disease that affects bone strength. Your doctor may check your bone density before and during treatment with exemestane. This is because medicines in this group reduce female hormone levels, which can lead to a loss of bone mineral content and may decrease bone strength.

Use in athletes

This medicine contains exemestane, which may produce a positive result in doping tests (see references in section 4.4 of the technical sheet).

Other medicines and Exemestane Aurovitas

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.

This medicine should not be taken at the same time as hormone replacement therapy (HRT).

The following medicines should be used with caution if you are being treated with exemestane. Tell your doctor if you are taking any of these medicines:

  • rifampicin (an antibiotic),
  • carbamazepine or phenytoin (antiepileptics used to treat epilepsy),
  • the herbal medicine St. John's Wort (Hypericum perforatum), or preparations that contain it.

Pregnancy, breastfeeding, and fertility

Do not take this medicine if you are pregnant or breastfeeding.

Tell your doctor if you are pregnant or think you may be pregnant.

Talk to your doctor about contraceptive measures if there is any chance you may become pregnant.

Driving and using machines

If you feel dizzy, drowsy, or tired while taking this medicine, do not drive or operate machinery.

Exemestane Aurovitas contains sodium

This medicine contains less than 1 mmol of sodium (23 mg) per tablet; it is essentially "sodium-free".

Exemestane Aurovitas contains lecithin (soy)

This medicine contains lecithin derived from soy. Do not use this medicine in case of peanut or soy allergy (see section 2 "Do not take Exemestane Aurovitas").

3. How to take Exemestane Aurovitas

Adult and elderly patients

Follow exactly the instructions for taking this medicine given by your doctor or pharmacist. If you are unsure, ask your doctor or pharmacist.

Exemestane should be taken orally, after a meal, at approximately the same time each day. Your doctor will tell you how to take this medicine and for how long.

The recommended dose is one 25 mg tablet per day.

If you need to go to the hospital while taking this medicine, inform the medical staff what medication you are taking.

Use in children

This medicine is not suitable for use in children.

If you take more Exemestane Aurovitas than you should

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount used. It is recommended to take the packaging and the leaflet to the healthcare professional.

If you forget to take Exemestane Aurovitas

Do not take a double dose to make up for forgotten doses.

If you forget to take a tablet, take it as soon as you remember. If it is near the time for the next dose, take it at the usual time.

If you stop taking Exemestane Aurovitas

Do not stop taking exemestane even if you feel well, unless your doctor tells you to.

If you have any other questions about the use of this medicine, ask your doctor, pharmacist, or nurse.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Hypersensitivity, liver inflammation (hepatitis), and inflammation of the bile ducts in the liver, which causes yellowing of the skin (cholestatic hepatitis), may occur. Symptoms include a feeling of general discomfort, nausea, jaundice (yellowing of the skin and eyes), itching, pain in the right side of the abdomen, and loss of appetite. Contact your doctor as soon as possible if you think you have any of these symptoms.

Generally, exemestane is well tolerated, and the following side effects observed in patients treated with this medicine are usually mild or moderate. Most side effects are related to the lack of estrogens (e.g., hot flashes).

Very common side effects (may affect more than 1 in 10 people):

  • Depression.
  • Difficulty sleeping.
  • Headache.
  • Hot flashes.
  • Dizziness.
  • Feeling unwell.
  • Increased sweating.
  • Pain in the joints and muscles (including osteoarthritis, back pain, arthritis, and stiffness in the joints).
  • Fatigue.
  • Decreased white blood cell count.
  • Abdominal pain.
  • High levels of liver enzymes.
  • High levels of hemoglobin breakdown in the blood.
  • High levels of blood enzymes in the blood due to liver damage.
  • Pain.

Common side effects (may affect up to 1 in 10 people):

  • Loss of appetite.
  • Carpal tunnel syndrome (a combination of tingling, numbness, and pain that affects the entire hand, except the little finger) or tingling/numbness in the skin.
  • Vomiting (nausea), constipation, indigestion, diarrhea.
  • Hair loss.
  • Rash, hives, and itching.
  • Bone loss that can reduce bone strength (osteoporosis) and may lead to fractures (breaks or cracks).
  • Swelling of hands and feet.
  • Decreased platelet count in the blood.
  • Feeling of muscle weakness.

Uncommon side effects (may affect up to 1 in 100 people):

  • Hypersensitivity.

Rare side effects (may affect up to 1 in 1,000 people):

  • Appearance of small blisters in a skin rash.
  • Drowsiness.
  • Liver inflammation.
  • Inflammation of the bile ducts in the liver that causes yellowing of the skin.

Frequency not known (cannot be estimated from the available data):

  • Low levels of certain white blood cells in the blood.

There may also be changes in the number of certain blood cells (lymphocytes) and platelets circulating in the blood, especially in patients with pre-existing lymphopenia (decreased lymphocytes in the blood).

Reporting of side effects

If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Medicines Agency's website: www.notificaRAM.es

5. Storage of Exemestane Aurovitas

Keep this medicine out of the sight and reach of children.

Do not use Exemestane Aurovitas after the expiry date stated on the pack after EXP. The expiry date is the last day of the month stated.

This medicine does not require any special storage conditions.

Medicines should not be disposed of via wastewater or household waste. Return any unused medicine to a pharmacy for disposal. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Contents of the pack and other information

Composition of Exemestane Aurovitas

The active substance is exemestane. Each film-coated tablet contains 25 mg of exemestane.

The other ingredients are:

Core of the tablet:pregelatinized starch, corn starch, microcrystalline cellulose (Grade-101), microcrystalline cellulose (Grade-102), crospovidone (Type A), sodium carboxymethyl starch (Type A) (potato), povidone (K 30), polysorbate 80, hydroxypropylcellulose (2.0 - 2.9 mPa.s), talc, anhydrous colloidal silica, magnesium stearate.

Coating of the tablet:poly(vinyl alcohol), titanium dioxide (E171), talc, lecithin (soy) (E322), xanthan gum.

Appearance of the product and pack contents

White to off-white film-coated tablets, approximately 6 mm, round, biconvex, with beveled edges and "25" engraved on one side and smooth on the other side.

Exemestane Aurovitas 25 mg film-coated tablets EFG are available in PVC/PVdC opaque white aluminum blister packs of 28, 30, 60, 98, 100, and 120 tablets.

Not all pack sizes may be marketed.

Marketing authorization holder:

Eugia Pharma (Malta) Limited

Vault 14, Level 2, Valletta Waterfront

Floriana, FRN 1914

Malta

Manufacturer:

APL Swift Services (Malta) Limited

HF26, Hal Far Industrial Estate, Hal Far

Birzebbugia, BBG 3000

Malta

Or

Generis Farmacêutica, S.A.

Rua João de Deus, 19

2700-487 Amadora

Portugal

Or

Arrow Génériques

26 Avenue Tony Garnier

69007 Lyon

France

You can ask for more information about this medicine by contacting the local representative of the marketing authorization holder:

Aurovitas Spain, S.A.U.

Avda. de Burgos, 16-D

28036 Madrid

Spain

This medicine is authorized in the Member States of the European Economic Area under the following names:

Germany: Exemestan PUREN 25 mg Filmtabletten

Spain: Exemestano Aurovitas 25 mg comprimidos recubiertos con película EFG

France: Exemestane ARROW LAB 25 mg, comprimé pelliculé.

Italy: Exemestane Aurobindo Italia

Malta: Exemestane Eugia 25 mg film-coated tablets

Portugal: Exemestano Generis

Date of last revision of this leaflet:July 2024

Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.

Online doctors for EXEMESTANE AUROVITAS 25 mg FILM-COATED TABLETS

Discuss questions about EXEMESTANE AUROVITAS 25 mg FILM-COATED TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80
5.0 (21)
Doctor

Giorgi Eremeishvili

Urology 22 years exp.

Giorgi Eremeishvili is a top-category urologist, a Candidate of Medical Sciences, and a licensed physician in Spain. He provides expert assistance in the diagnosis and treatment of a wide range of urological conditions in both men and women, employing a comprehensive approach and evidence-based principles.

Key areas of expertise:

  • Erectile dysfunction, decreased libido, premature ejaculation.
  • Male infertility: comprehensive diagnosis and modern treatment methods.
  • Prostate gland diseases: acute and chronic prostatitis, prostatic adenoma (benign prostatic hyperplasia), prostate cancer.
  • Inflammatory diseases of the genitourinary system: acute and chronic cystitis, pyelonephritis, epididymitis, orchitis, urethritis.
  • Sexually transmitted infections (STIs): chlamydia, ureaplasmosis, mycoplasmosis, gardnerellosis, candidiasis, herpetic infections, HPV, CMV, trichomoniasis, and others.
  • Urination disorders: urinary retention, frequent urination, urinary incontinence, overactive bladder, neurogenic bladder.
  • Neoplasms: cysts, tumors of the kidneys, bladder, testicles, prostate gland (including prostate cancer).
  • Surgical interventions: determining indications and selecting optimal minimally invasive methods.

Dr. Eremeishvili applies an integrated approach to each case. This includes thorough preoperative preparation, postoperative observation, and regular dynamic follow-up during the treatment process to achieve the best possible outcomes. All diagnostic and therapeutic recommendations are based on current evidence-based medicine and comply with the recommendations of the European Association of Urology, guaranteeing high-quality and effective care.

If you are seeking qualified assistance in diagnosing or treating urological conditions, book an online consultation with Dr. Giorgi Eremeishvili. Get expert support, accurate diagnosis, and a personalized treatment plan from the comfort of your home.

Camera Book a video appointment
€60
5.0 (29)
Doctor

Anna Biriukova

General medicine 6 years exp.

Dr Anna Biriukova is an internal medicine doctor with clinical experience in cardiology, endocrinology, and gastroenterology. She provides online consultations for adults, offering expert medical support for heart health, hormonal balance, digestive issues, and general internal medicine.

Cardiology – Diagnosis and treatment of:

  • High blood pressure, blood pressure fluctuations, and cardiovascular risk prevention.
  • Chest pain, shortness of breath, arrhythmias (tachycardia, bradycardia, palpitations).
  • Leg swelling, chronic fatigue, reduced exercise tolerance.
  • EKG interpretation, lipid profile evaluation, cardiovascular risk assessment (heart attack, stroke).
  • Post-COVID-19 cardiac monitoring and care.
Endocrinology – Diabetes, thyroid, metabolism:
  • Diagnosis and management of type 1 and type 2 diabetes, and prediabetes.
  • Individual treatment plans including oral medications and insulin therapy.
  • GLP-1 therapy– modern pharmacological treatment for weight management and diabetes control, including drug selection, monitoring, and safety follow-up.
  • Thyroid disorders – hypothyroidism, hyperthyroidism, autoimmune thyroid diseases (Hashimoto’s, Graves’ disease).
  • Metabolic syndrome – obesity, lipid disorders, insulin resistance.
Gastroenterology – Digestive health:
  • Abdominal pain, nausea, heartburn, gastroesophageal reflux (GERD).
  • Stomach and intestinal conditions: gastritis, irritable bowel syndrome (IBS), indigestion.
  • Management of chronic digestive disorders and interpretation of tests (endoscopy, ultrasound, labs).
General internal medicine and preventive care:
  • Respiratory infections – cough, colds, bronchitis.
  • Lab test analysis, therapy adjustments, medication management.
  • Adult vaccinations – planning, contraindications assessment.
  • Cancer prevention – screening strategies and risk assessment.
  • Holistic approach – symptom relief, complication prevention, and quality of life improvement.
Dr Biriukova combines internal medicine with specialist insight, offering clear explanations, personalised treatment plans, and comprehensive care tailored to each patient.
Camera Book a video appointment
€60
5.0 (29)
Doctor

Dmytro Horobets

Family medicine 7 years exp.

Dr. Dmytro Horobets is a licensed family medicine physician in Poland, specialising in endocrinology, diabetology, obesity management, gastroenterology, pediatrics, general surgery, and pain medicine. He offers online consultations for adults and children, providing personalised medical support for a wide range of acute and chronic health concerns.

Areas of expertise:

  • Endocrinology: diabetes type 1 and type 2, prediabetes, thyroid disorders, metabolic syndrome, hormonal imbalance.
  • Obesity medicine: structured weight management plans, nutritional counselling, obesity-related health risks.
  • Gastroenterology: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), liver and biliary conditions.
  • Pediatric care: infections, respiratory symptoms, digestive issues, growth and development monitoring.
  • General surgery support: pre- and post-surgical consultations, wound care, rehabilitation.
  • Pain management: chronic and acute pain, back pain, joint pain, post-traumatic pain syndromes.
  • Cardiovascular health: hypertension, cholesterol control, risk assessment for heart disease.
  • Preventive medicine: regular check-ups, health screenings, long-term management of chronic conditions.

Dr. Horobets combines evidence-based medicine with a patient-centred approach. He carefully evaluates each patient’s medical history and symptoms, offering clear explanations and structured treatment plans adapted to individual needs.

Whether you need help managing diabetes, tackling weight-related health issues, interpreting lab results, or receiving general family medicine support, Dr. Horobets provides professional online care tailored to your specific health goals.

Camera Book a video appointment
€60

Frequently Asked Questions

Is a prescription required for EXEMESTANE AUROVITAS 25 mg FILM-COATED TABLETS?
EXEMESTANE AUROVITAS 25 mg FILM-COATED TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in EXEMESTANE AUROVITAS 25 mg FILM-COATED TABLETS?
The active ingredient in EXEMESTANE AUROVITAS 25 mg FILM-COATED TABLETS is exemestane. This information helps identify medicines with the same composition but different brand names.
Who manufactures EXEMESTANE AUROVITAS 25 mg FILM-COATED TABLETS?
EXEMESTANE AUROVITAS 25 mg FILM-COATED TABLETS is manufactured by Eugia Pharma (Malta) Limited. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of EXEMESTANE AUROVITAS 25 mg FILM-COATED TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether EXEMESTANE AUROVITAS 25 mg FILM-COATED TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to EXEMESTANE AUROVITAS 25 mg FILM-COATED TABLETS?
Other medicines with the same active substance (exemestane) include AROMASIL 25 mg FILM-COATED TABLETS, EXEMESTANE AUROVITAS SPAIN 25 mg FILM-COATED TABLETS, EXEMESTANE CINFA 25 mg FILM-COATED TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media